184 related articles for article (PubMed ID: 1751019)
1. Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
Choi SW; Han JH; Lim KT; Cho HM; Chung KW; Sun HS; Park DH; Kim BS; Seo EJ
J Korean Med Sci; 1991 Jun; 6(2):146-56. PubMed ID: 1751019
[TBL] [Abstract][Full Text] [Related]
2. Cholic acid amelioration of light and electron microscopic hepatic lesions in experimental protoporphyria.
Lefkowitch JH; Feng-Chen KC; Sklar JA; Poh-Fitzpatrick MB
Hepatology; 1983; 3(3):399-406. PubMed ID: 6840685
[TBL] [Abstract][Full Text] [Related]
3. [The influence of ursodesoxycholic acid (URSO) on griseofulvin (GF)-induced protoporphyria].
Irifune H; Tsukazaki N; Watanabe M; Nonaka S
Nihon Hifuka Gakkai Zasshi; 1991 Jul; 101(8):813-7. PubMed ID: 1942584
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural changes of intrahepatic bile ductules in griseofulvin fed mice.
Shapiro SH; Wessely Z
Ann Clin Lab Sci; 1984; 14(1):69-77. PubMed ID: 6696389
[TBL] [Abstract][Full Text] [Related]
5. Experimental murine protoporphyria induced by griseofulvin (GF): the relationship between hepatic porphyrin levels and liver function test values in mice treated with GF.
Tanaka K; Ohgami T; Nonaka S
J Dermatol; 1993 Sep; 20(9):545-53. PubMed ID: 8227709
[TBL] [Abstract][Full Text] [Related]
6. Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
Berenson MM; Welch V; Garcia-Marin JJ
J Lab Clin Med; 1991 Jul; 118(1):89-98. PubMed ID: 2066649
[TBL] [Abstract][Full Text] [Related]
7. Light and electron microscopy of hepatocellular changes in griseofulvin fed mice. Particular reference to Mallory bodies.
Wessely Z; Shapiro SH; Klavins JV
Ann Clin Lab Sci; 1979; 9(1):24-36. PubMed ID: 420510
[TBL] [Abstract][Full Text] [Related]
8. Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment.
Knasmüller S; Parzefall W; Helma C; Kassie F; Ecker S; Schulte-Hermann R
Crit Rev Toxicol; 1997 Sep; 27(5):495-537. PubMed ID: 9347226
[TBL] [Abstract][Full Text] [Related]
9. Experimental induction of hepatocellular hyalin (Mallory bodies) in mice by griseofulvin treatment. 1. Light microscopic observation.
Denk H; Eckerstorfer R; Gschnait F; Konrad K; Wolff K
Lab Invest; 1976 Oct; 35(4):377-82. PubMed ID: 62098
[TBL] [Abstract][Full Text] [Related]
10. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
Kawahara H; Marceau N; French SW
Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
[TBL] [Abstract][Full Text] [Related]
11. Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.
Poh-Fitzpatrick MB; Sklar JA; Goldsman C; Lefkowitch JH
J Clin Invest; 1983 Oct; 72(4):1449-58. PubMed ID: 6630515
[TBL] [Abstract][Full Text] [Related]
12. Effects of ursodeoxycholic acid on intrahepatic cholestasis in rats.
Li L; Xu X; Lu F; Zhao N
Chin Med J (Engl); 2003 Jul; 116(7):1099-103. PubMed ID: 12890392
[TBL] [Abstract][Full Text] [Related]
13. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
14. Griseofulvin-induced cholestasis in Swiss albino mice.
Yokoo H; Craig RM; Harwood TR; Cochrane C
Gastroenterology; 1979 Nov; 77(5):1082-7. PubMed ID: 488635
[TBL] [Abstract][Full Text] [Related]
15. Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals.
Gschnait F; Konrad K; Hönigsmann H; Denk H; Wolff K
J Invest Dermatol; 1975 Sep; 65(3):290-9. PubMed ID: 1159316
[TBL] [Abstract][Full Text] [Related]
16. Manifestation of psychiatric behaviors in a mouse model of griseofulvin-induced hepatic porphyria.
Satoh Y; Iwadate R; Watanabe Y; Kawai H; Kudo N; Kawashima Y; Mitsumoto A
J Toxicol Sci; 2008 Dec; 33(5):599-608. PubMed ID: 19043281
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
[TBL] [Abstract][Full Text] [Related]
18. [Morphological changes in liver tissue in experimental porphyria].
Chlumská A; Dobiás J; Janousek V
Cesk Patol; 1978 May; 14(2):57-63. PubMed ID: 699108
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholic acid limits liver histologic alterations and portal hypertension induced by bile duct ligation in the rat.
Poo JL; Feldmann G; Erlinger S; Braillon A; Gaudin C; Dumont M; Lebrec D
Gastroenterology; 1992 May; 102(5):1752-9. PubMed ID: 1568585
[TBL] [Abstract][Full Text] [Related]
20. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
